Lowey Dannenberg Notifies Pacira Biosciences, Inc. (“Pacira” or the “Company”) (NASDAQ: PCRX) Investors of Securities Class Action Lawsuit and Encourages Investors with more than $100,000 in Losses to Contact the Firm — Neutral
PCRX GlobeNewsWire — February 14, 2025NEW YORK, Feb. 14, 2025 (GLOBE NEWSWIRE) -- Lowey Dannenberg P.C., a preeminent law firm in obtaining redress for consumers and investors, announces the filing of a class action lawsuit against Pacira Biosciences, Inc. (“Pacira” or the “Company”) (NASDAQ: PCRX) for violations of the federal securities laws on behalf of investors who purchased or acquired Pacira common stock between August 2, 2023 to August 8, 2024, inclusive (the “Class Period”).

Lowey Dannenberg Notifies Crocs, Inc. (“Crocs” or the “Company”) (NASDAQ: CROX) Investors of Securities Class Action Lawsuit and Encourages Investors with more than $100,000 in Losses to Contact the Firm — Neutral
CROX GlobeNewsWire — February 14, 2025NEW YORK, Feb. 14, 2025 (GLOBE NEWSWIRE) -- Lowey Dannenberg P.C., a preeminent law firm in obtaining redress for consumers and investors, announces the filing of a class action lawsuit against Crocs, Inc. (“Crocs” or the “Company”) (NASDAQ: CROX) for violations of the federal securities laws on behalf of investors who purchased or acquired Crocs common stock between November 3, 2022, and October 28, 2024, inclusive (the “Class Period”).

4 PEG-Based Value Stocks to Shield Your Portfolio From Trade War — Positive
EXPE GM PAHC PPC Zacks Investment Research — February 14, 2025Here are four PEG-driven GARP stocks, GM, EXPE, PAHC and PPC, which qualify our screening criteria.

Should You Buy, Sell, or Hold Comfort Systems Stock at 23.25X P/E? — Negative
FIX Zacks Investment Research — February 14, 2025Comfort Systems USA FIX is currently trading at a forward 12-month price-to-earnings (P/E) ratio of 23.25. This is notably lower than the industry average of 29.52, making the stock look attractive on a relative valuation basis.

Vulcan to Report Q4 Earnings: Here's What Investors Should Know — Neutral
VMC Zacks Investment Research — February 14, 2025VMC's fourth-quarter 2024 performance is likely to reflect its focus on pricing, cost control, and infrastructure-driven demand amid soft residential activity.

Lowey Dannenberg Notifies Novo Nordisk A/S (“Novo” or the “Company”) (NYSE: NVO) Investors of Securities Class Action Lawsuit and Encourages Investors with more than $200,000 in Losses to Contact the Firm — Neutral
NVO GlobeNewsWire — February 14, 2025NEW YORK, Feb. 14, 2025 (GLOBE NEWSWIRE) -- Lowey Dannenberg P.C., a preeminent law firm in obtaining redress for consumers and investors, announces the filing of a class action lawsuit against Novo Nordisk A/S (“Novo” or the “Company”) (NYSE: NVO) for violations of the federal securities laws on behalf of investors who purchased or acquired Novo common stock between November 2, 2022 to December 19, 2024, inclusive (the “Class Period”).

CNBC's Kristina Partsinevelos joins 'Squawk on the Street' to discuss the latest news in the chips space.

AFK: So Contrarian, It Just Might Work (New Buy Rating) — Positive
AFK Seeking Alpha — February 14, 2025AFK invests in a portfolio of stocks that do most of their business on the continent of Africa. It is the only US-traded ETF that can say that. South African gold miners are part of the portfolio but don't dominate it, there is good non-tech diversification here. AFK's portfolio sells for about 10x trailing earnings. That, the chart pattern (long-term) and the potential for this market to be discovered make it a speculative buy.

Brown-Forman: Caught In The Perfect Storm, Finally A Buy (Rating Upgrade) — Positive
BF-A BF-B Seeking Alpha — February 14, 2025Brown-Forman Corporation stock is in the midst of a perfect storm characterized by a massive inventory overhang, a weak demand environment, rebounding inflation and, of course, the threat of tariffs. In this update, I explain why I – quite counterintuitively – finally moved BF.A/BF.B from my watch list to my buy list. However, due to the likely continued volatile environment and the possibility of a temporarily reduced dividend or outright suspension, I am proceeding cautiously in building up my position.

Tevogen Bio CEO Addresses Short Selling and Its Potential Impact on the Nation's Health and Prosperity — Neutral
TVGN GlobeNewsWire — February 14, 2025CEO of Tevogen Bio, Dr. Saadi addresses short selling and its potential impact on the nation's health and prosperity. Reaffirms commitment to shareholders.

Cementos Pacasmayo S.A.A. (CPAC) Q4 2024 Earnings Conference Call Transcript — Neutral
CPAC Seeking Alpha — February 14, 2025Cementos Pacasmayo S.A.A. (NYSE:CPAC ) Q4 2024 Earnings Conference Call February 14, 2025 9:00 AM ET Company Participants Claudia Bustamante - IR Manager Humberto Nadal - CEO Manuel Ferreyros - CFO Conference Call Participants Marcelo Furlan - Itau Adrian Huerta - JP Morgan Francisco Suarez - Scotiabank Luis Ramos - Larrain Vial Gabriel Perez - CrediCorp Operator Good day, ladies and gentlemen.

CBOE: Downgrading To Hold Amid Rising Costs And Intensified Competition — Negative
CBOE Seeking Alpha — February 14, 2025I am downgrading Cboe Global Markets, Inc. from a 'buy' to a 'hold' due to lackluster profitability growth and rising expenses outpacing revenue growth. Recent results showed revenue growth but missed estimates, with operating expenses climbing 10%, leading to EBITDA margin contraction and EPS falling short of expectations. Despite strong performance in derivatives and Data Vantage businesses, competition and expense growth pose risks to sustaining high EBITDA margins and profitability.

Wynn Resorts Stock Pops on Earnings. Why Analysts Say It's a Buy. — Positive
WYNN Barrons — February 14, 2025Wynn Resorts tops expectations for fourth-quarter earnings and revenue.

Exclusive: EU set to clear Nokia's $2.3 bln Infinera deal without conditions, sources say — Positive
INFN NOK Reuters — February 14, 2025EU antitrust regulators are set to clear without conditions Nokia's $2.3 billion acquisition of U.S. optical semiconductors and networking equipment maker Infinera , people with direct knowledge of the matter said on Friday.

ROSEN, TRUSTED INVESTOR COUNSEL, Encourages TELUS International (Cda) Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - TIXT — Neutral
TIXT Accesswire — February 14, 2025NEW YORK, NY / ACCESS Newswire / February 14, 2025 / WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of TELUS International (Cda) Inc. (NYSE:TIXT) between February 16, 2023 and August 1, 2024, both dates inclusive (the "Class Period"), of the important March 31, 2025 lead plaintiff deadline. SO WHAT: If you purchased TELUS International securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

The Goodyear Tire & Rubber Company (GT) Q4 2024 Earnings Call Transcript — Neutral
GT Seeking Alpha — February 14, 2025The Goodyear Tire & Rubber Company (NASDAQ:GT ) Q4 2024 Results Conference Call February 14, 2025 9:00 AM ET Company Participants Greg Shank - Senior Director, IR Mark Stewart - CEO and President Christina Zamarro - EVP and CFO Conference Call Participants James Picariello - BNP Paribas Emmanuel Rosner - Wolfe Research Doug Karson - Bank of America Edison Yu - Deutsche Bank Operator Good morning. My name is Margo, and I'll be your conference operator today.

Global Partners LP to Host Fourth-Quarter and Full-Year 2024 Financial Results Conference Call on February 28, 2025 — Neutral
GLP Business Wire — February 14, 2025WALTHAM, Mass.--(BUSINESS WIRE)--Global Partners LP (NYSE: GLP) (the “Partnership”) today announced that it will release its fourth-quarter and full-year 2024 financial results before the market opens on Friday, February 28, 2025. At 10:00 a.m. ET, the Partnership will conduct a conference call for investors and analysts hosted by Eric Slifka, President and Chief Executive Officer, Gregory B. Hanson, Chief Financial Officer, and Mark Romaine, Chief Operating Officer. The call can be accessed by.

Enbridge Inc. (ENB) Q4 2024 Earnings Call Transcript — Neutral
ENB Seeking Alpha — February 14, 2025Enbridge Inc. (NYSE:ENB ) Q4 2024 Earnings Conference Call February 14, 2025 9:00 AM ET Company Participants Rebecca Morley - Vice President, Investor Relations Greg Ebel - President and CEO Pat Murray - Executive Vice President and CFO Colin Gruending - President, Liquids Pipelines Cynthia Hansen - President, Gas Transmission and Midstream Michele Harradence - Head, Gas Distribution and Storage Matthew Akman - President, Renewable Power Conference Call Participants Jeremy Tonet - JPMorgan Robert Catellier - CIBC Capital Markets Ben Pham - BMO Capital Markets Manav Gupta - UBS Maurice Choy - RBC Capital Markets Rob Hope - Scotiabank Theresa …

Informatica's stock plunges after ‘messy' Q4 results, but analysts see positives — Negative
INFA Market Watch — February 14, 2025Informatica CEO Amit Walia said that “execution issues” are being addressed by the data-management-software company.

Lowey Dannenberg Notifies Neumora Therapeutics, Inc. (“Neumora” or the “Company”) (NASDAQ: NMRA) Investors of Securities Class Action Lawsuit and Encourages Investors with more than $100,000 in Losses to Contact the Firm — Neutral
NMRA GlobeNewsWire — February 14, 2025NEW YORK, Feb. 14, 2025 (GLOBE NEWSWIRE) -- Lowey Dannenberg P.C., a preeminent law firm in obtaining redress for consumers and investors, announces the filing of a class action lawsuit against Neumora Therapeutics, Inc. (“Neumora” or the “Company”) (NASDAQ: NMRA) for violations of the federal securities laws on behalf of investors who purchased or acquired Neumora common stock at the time of the Company's Initial Public Offering (“IPO”) on September 15, 2023.
